The investigational status of retatrutide and the limited population size of pre-Phase-3 trials mean less is known about long-term and rare adverse events than for FDA-approved tirzepatide or semaglutide
Gaschler, M.M., Andia, A.A., Liu, H., et al
Florida Blue plans may cover GLP-1 medications like Wegovy or Ozempic, but: Insurance approval often depends on how the request is documented, says Dr
A lip filler treatment uses dermal fillers to enhance lip volume, definition, and hydration
Individuals may be prescribed compounded tirzepatide for various reasons, such as requiring an individualized customized dose unavailable commercially, or to maintain continuity of care
At higher doses, patients lost an average of nearly a quarter of their body weight, exceeding outcomes typically reported with current licensed treatments such as Wegovy (~15%) or Mounjaro (~20%)